Early Intervention with Transtympanic Methylprednisolon Is Effective Therapy in Idiopathic Sudden Sensorineural Hearing Loss
International Journal of Current Pharmaceutical Review and Research · 30.07.2026 · 18 (07)
DOI: 10.25258/ijcpr.18.7.103 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 30.07.2026. Verfasst von Sudhir Halikar.
Abstract (Originalsprache)
Background
Idiopathic sudden sensorineural hearing loss is a not so uncommon condition affecting individuals with potential risk of permanent hearing loss if not treated on time. Steroids are the main stay of therapy and in recent years transtympanic steroid therapy is getting popular for its effectiveness in the management of Idiopathic SSNHL.
Aim
To evaluate efficacy of early intervention with transtympanic methylprednisolon in Idiopathic sudden sensorineural hearing loss Methods: In a retrospective study over a period of 4 yrs, 32 patients with idiopathic sudden sensorineural hearing loss were treated with transtympanic methylprdnisolon in combination with or without oral steroid therapy. Pretreatment and post treatment audiometric evaluation was done. Transtympanic methylprednisolon was given in the dose of 0.4 ml of 10 mg/ml alternate days for total 5 instilations.
Results
A statistically significant association was found between the time at which medical intervention in the form of transtympanic methylprednisolon was started and hearing improvement without any side effects of the drug. Amongst 32 patients, 25 pts showed significant improvement in the hearing [more than 20 db improvement on audiogram]. 14 of these pts was on only oral steroids but hearing improved significantly after starting transtympanic therapy. 7 patients who consulted in the first week got best results of 90% improvement in hearing and in the rest of the patient’s percentage of recovery reduced by every passing day and week, with no improvement when intervention was made after one month of hearing loss. Notably almost all patients suggested improvement in tinnitus and aural pressure before hearing improvement.
Conclusion
Early diagnosis and intervention with transtympanic methylprednisolone has best results in Idiopathic sudden sensorineural hearing loss.
Zitieren
APA
Halikar, S. (2026). Early Intervention with Transtympanic Methylprednisolon Is Effective Therapy in Idiopathic Sudden Sensorineural Hearing Loss. International Journal of Current Pharmaceutical Review and Research, 18(07). https://doi.org/10.25258/ijcpr.18.7.103
Vancouver
Halikar S. Early Intervention with Transtympanic Methylprednisolon Is Effective Therapy in Idiopathic Sudden Sensorineural Hearing Loss. International Journal of Current Pharmaceutical Review and Research. 2026;18(07). doi:10.25258/ijcpr.18.7.103
BibTeX
@article{Halikar2026,
author = {Halikar, Sudhir},
title = {Early Intervention with Transtympanic Methylprednisolon Is Effective Therapy in Idiopathic Sudden Sensorineural Hearing Loss},
journal = {International Journal of Current Pharmaceutical Review and Research},
year = {2026},
volume = {18},
number = {07},
doi = {10.25258/ijcpr.18.7.103}
}
EUVIMED